BM
BLUE

Brandywine Managers’s bluebird bio BLUE Stock Holding History

Brandywine Managers’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-216
Closed -$246K – 42
2019
Q4 		$246K Buy
216
+23
+12% +$25K 0.07% 42
2019
Q3 		$230K Buy
193
+39
+25% +$59.6K 0.08% 41
2019
Q2 		$254K Hold
154
– – 0.1% 42
2019
Q1 		$315K Buy
+154
New +$271K 0.13% 38

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brandywine Managers's BLUE Position: Q1 2020 in Review

Brandywine Managers sold out of bluebird bio (BLUE) in Q1 2020, closing a stake of 216 shares — an estimated $246K sold.

Brandywine Managers first reported a position in BLUE in Q1 2019 and held it in 4 quarters. The position peaked at $315K in Q1 2019. 247 funds tracked by Wall St. Rank hold BLUE as of Q1 2020.

  • Brandywine Managers reported no remaining bluebird bio position as of Q1 2020 after selling out during the quarter.
  • Brandywine Managers sold 216 bluebird bio shares in Q1 2020, an estimated $246K.
  • Brandywine Managers first reported a position in bluebird bio in Q1 2019 and held it in 4 quarters.
  • Brandywine Managers's bluebird bio position peaked at $315K in Q1 2019.
  • 247 funds tracked by Wall St. Rank held bluebird bio as of Q1 2020.

Based on Brandywine Managers's 13F filing for Q1 2020, filed 15 May 2020.